University of Cologne-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2024

  1. Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK

    Journal of Hospital Infection, Vol. 147, pp. 123-132

2022

  1. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

    Clinical Microbiology and Infection, Vol. 28, Núm. 4, pp. 580-587

2021

  1. Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics

    Nature Communications, Vol. 12, Núm. 1

  2. Microbiota-based markers predictive of development of Clostridioides difficile infection

    Nature Communications, Vol. 12, Núm. 1

  3. Mixinyeast: A multicenter study on mixed yeast infections

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-14

2020

  1. Exploratory evaluation of bezlotoxumab on outcomes associated with clostridioides difficile infection in MODIFY I/II Participants with Cancer

    Open Forum Infectious Diseases, Vol. 7, Núm. 2

  2. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey

    Mycoses, Vol. 63, Núm. 5, pp. 420-429

2018

  1. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    Clinical Microbiology and Infection, Vol. 24, pp. e1-e38

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

2014

  1. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 5-26

  2. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 76-98

  3. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: Diseases caused by black fungi

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 47-75

  4. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 27-46

2007

  1. Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad Trial)

    Clinical Infectious Diseases, Vol. 44, Núm. 10, pp. 1289-1297